CY1108724T1 - ΑΝΟΣΟΠΟΙΗΣΗ ΓΑΛΑΚΤΟΠΑΡΑΓΩΓΩΝ ΑΓΕΛΑΔΩΝ ΜΕ ΧΙΜΑΙΡΙΚΗ GapC ΠΡΩΤΕΪΝΗ ΕΝΑΝΤΙ ΜΟΛΥΝΣΗΣ ΣΤΡΕΠΤΟΚΟΚΚΟΥ - Google Patents
ΑΝΟΣΟΠΟΙΗΣΗ ΓΑΛΑΚΤΟΠΑΡΑΓΩΓΩΝ ΑΓΕΛΑΔΩΝ ΜΕ ΧΙΜΑΙΡΙΚΗ GapC ΠΡΩΤΕΪΝΗ ΕΝΑΝΤΙ ΜΟΛΥΝΣΗΣ ΣΤΡΕΠΤΟΚΟΚΚΟΥInfo
- Publication number
- CY1108724T1 CY1108724T1 CY20091100094T CY091100094T CY1108724T1 CY 1108724 T1 CY1108724 T1 CY 1108724T1 CY 20091100094 T CY20091100094 T CY 20091100094T CY 091100094 T CY091100094 T CY 091100094T CY 1108724 T1 CY1108724 T1 CY 1108724T1
- Authority
- CY
- Cyprus
- Prior art keywords
- immunization
- chemical
- milk products
- gapc protein
- protein against
- Prior art date
Links
- 206010061372 Streptococcal infection Diseases 0.000 title abstract 2
- 101150093511 GAPC gene Proteins 0.000 title 1
- 101150115724 GAPC1 gene Proteins 0.000 title 1
- 230000003053 immunization Effects 0.000 title 1
- 238000002649 immunization Methods 0.000 title 1
- 239000008267 milk Substances 0.000 title 1
- 210000004080 milk Anatomy 0.000 title 1
- 235000013336 milk Nutrition 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 241000194017 Streptococcus Species 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 229920001817 Agar Polymers 0.000 abstract 1
- 241000222518 Agaricus Species 0.000 abstract 1
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 241000194042 Streptococcus dysgalactiae Species 0.000 abstract 1
- 239000008272 agar Substances 0.000 abstract 1
- 108091008324 binding proteins Proteins 0.000 abstract 1
- 208000004396 mastitis Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 229940115920 streptococcus dysgalactiae Drugs 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56944—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Abstract
Περιγράφεται η ανασυνδυασμένη παρασκευή της Gap4, μιας χιμαιρικής πρωτεΐνης σύνδεσης πλασμίνης GapC, που περιλαμβάνει την πλήρη αλληλουχία αμινοξέος της GapC πρωτεΐνης Streptococcus dysgalactiae, επιπλέον προς τις μοναδικές αλληλουχίες αμινοξέος από τις Streptococcus parauberis και Streptococcus agalactiae GapC πρωτεΐνες. Περιγράφεται επίσης η χρήση Gap4 χιμαιρικής GapC πρωτεΐνης σε συνθέσεις εμβολίου για να αποτρέπονται ή να θεραπεύονται στρεπτοκοκκικές μολύνσεις γενικά και ιδιαιτέρως μαστίτιδα.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21124700P | 2000-06-12 | 2000-06-12 | |
EP01944803A EP1294771B1 (en) | 2000-06-12 | 2001-06-11 | Chimeric GapC protein from Streptococcus and its use in vaccination and diagnosis |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1108724T1 true CY1108724T1 (el) | 2014-04-09 |
Family
ID=22786123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20091100094T CY1108724T1 (el) | 2000-06-12 | 2009-01-27 | ΑΝΟΣΟΠΟΙΗΣΗ ΓΑΛΑΚΤΟΠΑΡΑΓΩΓΩΝ ΑΓΕΛΑΔΩΝ ΜΕ ΧΙΜΑΙΡΙΚΗ GapC ΠΡΩΤΕΪΝΗ ΕΝΑΝΤΙ ΜΟΛΥΝΣΗΣ ΣΤΡΕΠΤΟΚΟΚΚΟΥ |
Country Status (12)
Country | Link |
---|---|
US (4) | US6660270B2 (el) |
EP (1) | EP1294771B1 (el) |
AR (1) | AR028713A1 (el) |
AT (1) | ATE412673T1 (el) |
CA (1) | CA2411919C (el) |
CY (1) | CY1108724T1 (el) |
DE (1) | DE60136356D1 (el) |
DK (1) | DK1294771T3 (el) |
ES (1) | ES2316450T3 (el) |
PT (1) | PT1294771E (el) |
UY (1) | UY26763A1 (el) |
WO (1) | WO2001096379A2 (el) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6833134B2 (en) * | 2000-06-12 | 2004-12-21 | University Of Saskacthewan | Immunization of dairy cattle with GapC protein against Streptococcus infection |
JP2005535350A (ja) | 2002-08-12 | 2005-11-24 | アクゾ・ノベル・エヌ・ベー | ストレプトコッカス・ユベリス蛋白質、前記蛋白質をコードする核酸配列及び乳腺炎ワクチンにおけるその使用 |
US20070048096A1 (en) * | 2004-12-07 | 2007-03-01 | Hubbs Jonathan W | Soil conditioner |
US20060118009A1 (en) * | 2004-12-07 | 2006-06-08 | Hubbs Jonathan W | Soil conditioner |
US7951384B2 (en) * | 2005-08-05 | 2011-05-31 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
US9216212B2 (en) | 2005-08-05 | 2015-12-22 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
US8012730B1 (en) * | 2006-08-29 | 2011-09-06 | The United States Of America As Represented By The Secretary Of Agriculture | Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin |
EP2023143A1 (en) * | 2007-08-06 | 2009-02-11 | Boehringer Ingelheim Vetmedica Gmbh | Immunogenic streptococcus proteins |
US20100088957A1 (en) * | 2008-10-09 | 2010-04-15 | Hubbs Jonathan W | Natural turf with binder |
US20100216639A1 (en) * | 2009-02-20 | 2010-08-26 | Hubbs Jonathon W | Gypsum soil conditioner |
US8147849B2 (en) * | 2009-02-20 | 2012-04-03 | Novartis Ag | Protective antigens for group B Streptococcus hypervirulent strains |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE459503B (sv) | 1985-05-03 | 1989-07-10 | Excorim Kommanditbolag | Hybrid-dna-molekyl innefattande dna-sekvens som kodar foer protein g samt foerfarande foer framstaellning av protein g |
US4954618A (en) | 1986-02-14 | 1990-09-04 | Genex Corporation | Cloned streptococcal genes encoding protein G and their use to construct recombinant microorganisms to produce protein G |
US5198215A (en) * | 1987-06-22 | 1993-03-30 | Noordzee Laboratorium N.V. | Composition for controlling mastitis in ruminants, method for its preparation and method of treatment of ruminants |
US4977082A (en) | 1987-12-10 | 1990-12-11 | University Of Florida Research Foundation, Inc. | Type VI bacterial FC receptors |
US5472696A (en) | 1988-02-26 | 1995-12-05 | Univ. Of Florida Research Foundation, Inc. | Antigen of group B streptococci |
US5328996A (en) | 1989-03-29 | 1994-07-12 | University Of Florida Research Foundation, Inc. | Bacterial plasmin receptors as fibrinolytic agents |
US5237050A (en) | 1989-03-29 | 1993-08-17 | University Of Florida Research Foundation, Inc. | Bacterial plasmin receptors as fibrinolytic agents |
US5476929A (en) * | 1991-02-15 | 1995-12-19 | Uab Research Foundation | Structural gene of pneumococcal protein |
EP0672123A1 (en) * | 1992-01-08 | 1995-09-20 | The Rockefeller University | Multifunctional surface protein of streptococci |
WO1994006421A1 (en) * | 1992-09-16 | 1994-03-31 | The University Of Tennessee Research Corporation | Recombinant multivalent m protein vaccine |
HUP0600442A3 (en) | 1995-06-07 | 2007-03-28 | Biochem Vaccines Inc | Streptococcal heat shock proteins members of the hsp70 family |
CA2222701C (en) | 1995-06-08 | 2012-02-07 | University Of Saskatchewan | Camp factor of streptococcus uberis |
US5863543A (en) | 1996-06-05 | 1999-01-26 | University Of Saskatchewan | Camp factor of streptococcus uberis |
WO1997036924A1 (fr) * | 1996-03-29 | 1997-10-09 | Nippon Zeon Co., Ltd. | Nouvelle proteine fusionnee, gene s'y rapportant, vecteur recombinant, virus recombinant et leur utilisation |
DE69737125T3 (de) | 1996-10-31 | 2015-02-26 | Human Genome Sciences, Inc. | Streptococcus pneumoniae-Antigene und Impfstoffe |
US6485904B1 (en) | 1997-06-23 | 2002-11-26 | Pfizer, Inc. | DNA encoding a plasminogen activating protein |
TR200002437T2 (tr) | 1998-02-20 | 2000-11-21 | Biochem Pharma Inc. | B grubu streptococcus antijenleri. |
WO2000039299A2 (en) | 1998-12-23 | 2000-07-06 | Shire Biochem Inc. | Streptococcus antigens |
US6391316B1 (en) * | 1999-03-10 | 2002-05-21 | University Of Saskatchewan | Vaccine compositions comprising Haemophilus somnus transferrin-binding proteins and methods of use |
-
2001
- 2001-06-11 US US09/878,766 patent/US6660270B2/en not_active Expired - Lifetime
- 2001-06-11 DE DE60136356T patent/DE60136356D1/de not_active Expired - Lifetime
- 2001-06-11 WO PCT/CA2001/000836 patent/WO2001096379A2/en active Application Filing
- 2001-06-11 DK DK01944803T patent/DK1294771T3/da active
- 2001-06-11 ES ES01944803T patent/ES2316450T3/es not_active Expired - Lifetime
- 2001-06-11 PT PT01944803T patent/PT1294771E/pt unknown
- 2001-06-11 CA CA2411919A patent/CA2411919C/en not_active Expired - Fee Related
- 2001-06-11 EP EP01944803A patent/EP1294771B1/en not_active Expired - Lifetime
- 2001-06-11 AT AT01944803T patent/ATE412673T1/de active
- 2001-06-12 AR ARP010102798A patent/AR028713A1/es not_active Application Discontinuation
- 2001-06-12 UY UY26763A patent/UY26763A1/es not_active IP Right Cessation
-
2003
- 2003-08-27 US US10/650,369 patent/US6875853B2/en not_active Expired - Lifetime
-
2005
- 2005-02-25 US US11/066,594 patent/US7258992B2/en not_active Expired - Fee Related
-
2007
- 2007-07-09 US US11/825,796 patent/US20080009022A1/en not_active Abandoned
-
2009
- 2009-01-27 CY CY20091100094T patent/CY1108724T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
US6660270B2 (en) | 2003-12-09 |
US20080009022A1 (en) | 2008-01-10 |
WO2001096379A3 (en) | 2002-08-08 |
PT1294771E (pt) | 2009-01-06 |
EP1294771B1 (en) | 2008-10-29 |
CA2411919A1 (en) | 2001-12-20 |
EP1294771A2 (en) | 2003-03-26 |
WO2001096379A2 (en) | 2001-12-20 |
US6875853B2 (en) | 2005-04-05 |
AR028713A1 (es) | 2003-05-21 |
ES2316450T3 (es) | 2009-04-16 |
US20020044928A1 (en) | 2002-04-18 |
DK1294771T3 (da) | 2008-12-15 |
US7258992B2 (en) | 2007-08-21 |
CA2411919C (en) | 2012-07-31 |
UY26763A1 (es) | 2001-08-27 |
DE60136356D1 (de) | 2008-12-11 |
US20040062774A1 (en) | 2004-04-01 |
US20050142615A1 (en) | 2005-06-30 |
ATE412673T1 (de) | 2008-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108724T1 (el) | ΑΝΟΣΟΠΟΙΗΣΗ ΓΑΛΑΚΤΟΠΑΡΑΓΩΓΩΝ ΑΓΕΛΑΔΩΝ ΜΕ ΧΙΜΑΙΡΙΚΗ GapC ΠΡΩΤΕΪΝΗ ΕΝΑΝΤΙ ΜΟΛΥΝΣΗΣ ΣΤΡΕΠΤΟΚΟΚΚΟΥ | |
DK0950068T3 (da) | Kollagen-bindende proteinsammensatninger og fremgangsmade til anvendelse | |
CY1117065T1 (el) | Υβριδικη και διαδοχικη εκφραση νεϊσσεριακα λαμβανομενων πρωτεϊνων | |
CY1105008T1 (el) | Αντιμικροβιακη ενεργοτητα του πρωτου κατιονικου συγκροτηματος της ανθρωπινης λακτοφερρινης | |
CY1113650T1 (el) | Συντηρημενα αντιγονα neisseria | |
CY1107702T1 (el) | Πολυπεπτιδια, νουκλεϊκα οξεα στρεπτοκοκκου ομαδας β και θεραπευτικες συνθεσεις και εμβολια αυτων | |
WO2023094713A3 (en) | Coronavirus vaccine | |
ES2137310T3 (es) | Vacuna contra una infeccion por streptococcus suis. | |
WO2003065973A3 (en) | Multivalent streptococcal vaccine compositions and methods for use | |
WO1998049311A3 (en) | Ricin-like toxin variants for treatment of cancer, viral or parasitic infections | |
WO2002034773A3 (en) | Streptococcal genes | |
WO2001081380A3 (en) | Immunogenic pneumococcal protein and vaccine compositions thereof | |
WO2023147092A3 (en) | Coronavirus vaccine | |
ES2444693T3 (es) | Polipéptido derivado de enterococo y su uso para vacunación | |
ATE362481T1 (de) | Lantibiotikum | |
DE69841073D1 (de) | Fibronektinbindungsprotein abgeleitete peptide, die nicht an fibronektin binden, antikörper dagegen und therapeutische anwendung | |
TR200400049T2 (tr) | Eimeria maxima gametositinden rekombinant 56 ve 82 kda antijenleri kodlayan nükleik asitler | |
UY26764A1 (es) | Inmunización del ganado lacteo con proteína gapc contra infección por estreptococo. | |
CY1107670T1 (el) | Ανοσοποιηση γαλακτοπαραγωγων αγελαδων με πρωτεϊνη mig | |
DK1146889T3 (da) | Identifikation af specifikke differentielt udtrykte mycobakterielle antigener og medicinsk anvendelse af Mycobakteriumproteinerne Rv0068 og Rv3407 | |
AU2003281917A8 (en) | Vaccine against infections caused by oncoviruses such as the feline leucosis virus of cats | |
HUP0200162A2 (hu) | Haemophilus somnus transzferrin-kötő fehérjék klónozása és expresszálása | |
WO2003064446A3 (en) | Plasma protein-binding peptides from bacterial curli | |
EP1734050A3 (en) | Immunization of dairy cattle with GapC protein against streptococcus infection | |
CY1107374T1 (el) | Εμβολιο ιχθυος εναντι της piscirickettsia salmonis |